Is lisinopril bad for your kidneys
Pro Research Analysisby 
Searched over 200M research papers
Impact of Lisinopril on Kidney Health
Introduction to Lisinopril and Kidney Function
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is commonly prescribed for managing hypertension and heart failure. Its effects on kidney function, particularly in patients with various forms of nephropathy, have been extensively studied. This article synthesizes research findings to address whether lisinopril is detrimental to kidney health.
Lisinopril in Diabetic Nephropathy
Comparative Studies with Atenolol
Several studies have compared the effects of lisinopril with other antihypertensive agents like atenolol in patients with diabetic nephropathy. Research indicates that both lisinopril and atenolol effectively reduce blood pressure and slow the decline in kidney function. However, lisinopril has shown a more significant reduction in albuminuria, a marker of kidney damage, compared to atenolol . This suggests that lisinopril may offer additional renoprotective benefits beyond blood pressure control.
Long-Term Effects
In a long-term study involving type 1 diabetic patients with diabetic nephropathy, lisinopril was compared with nisoldipine, a calcium antagonist. Both drugs were found to have similar beneficial effects on the progression of diabetic nephropathy over four years. However, lisinopril significantly reduced albuminuria, indicating its potential for better kidney protection.
Lisinopril in Non-Diabetic Nephropathies
Proteinuria and Renal Function
Lisinopril has also been studied in patients with non-diabetic chronic renal diseases. In a study involving patients with mild proteinuria, lisinopril was more effective than other antihypertensive agents in slowing the progression of renal insufficiency. The study concluded that lisinopril has a specific renoprotective effect, in addition to its blood pressure-lowering capabilities.
Chronic Allograft Nephropathy
In patients with chronic allograft nephropathy, lisinopril was shown to reduce proteinuria and preserve graft function over a year. This suggests that lisinopril can be safely used in renal transplant patients without adversely affecting graft function.
Safety Concerns and Adverse Effects
Combination Therapy Risks
While lisinopril alone has shown beneficial effects, combination therapy with ACE inhibitors and angiotensin-receptor blockers (ARBs) has raised safety concerns. A study involving combination therapy with lisinopril and losartan in diabetic nephropathy patients was stopped early due to increased risks of hyperkalemia and acute kidney injury. This highlights the importance of cautious use and monitoring when combining these medications.
Lipid Abnormalities and Chronic Nephropathies
Lisinopril has also been studied for its effects on lipid abnormalities in chronic nephropathies. Increasing doses of lisinopril were found to safely reduce proteinuria and improve lipid profiles without significantly affecting renal hemodynamics. This indicates that lisinopril can be beneficial in managing both kidney function and lipid abnormalities in chronic nephropathies.
Conclusion
Overall, the evidence suggests that lisinopril is not inherently harmful to the kidneys. In fact, it offers significant renoprotective benefits, particularly in reducing proteinuria and slowing the progression of nephropathy in both diabetic and non-diabetic patients. However, caution is advised when using combination therapies involving lisinopril due to potential adverse effects. Regular monitoring and individualized treatment plans are essential to maximize the benefits and minimize the risks associated with lisinopril therapy.
Sources and full results
Most relevant research papers on this topic